As the major impediment for treating PC is the rapid development of chemoresistance to the current standard therapy, gemcitabine (GEM)27, we next investigated whether clock dysfunction affects the GEM response in PC cells. The gene discussed is CLOCK; the disease is pachyonychia congenita.